MIT showcases sensor technology that allows for blood glucose monitoring on smartwatches.

      The finger prick could soon become obsolete, thanks to MIT.

      Monitoring blood sugar multiple times a day is one of the most challenging aspects of diabetes management. It involves pricking your finger to draw blood and repeating the process several times. Researchers at MIT may have discovered a method to eliminate this procedure.

      MIT scientists have created a shoebox-sized device capable of measuring blood glucose levels without the use of needles. The device employs a technique called Raman spectroscopy, which involves shining near-infrared light onto the skin and examining how the light interacts with the tissue's molecules.

      This device detects glucose signals located just beneath the skin’s surface, eliminating the need for wire insertions or finger pricks.

      So, how precise is it?

      It turns out it is quite accurate. In tests involving a healthy volunteer, the device's readings corresponded to those given by commercial glucose monitors that require an embedded sensor.

      Measurements were recorded every five minutes over a four-hour timeframe while the subject consumed two glucose drinks to assess the device across various blood sugar levels.

      Each reading takes a bit over 30 seconds, which is relatively quick for a noninvasive technique.

      “If we can develop a noninvasive glucose monitor with high precision, it would benefit nearly everyone with diabetes,” stated Jeon Woong Kang, a research scientist at MIT and the lead author of the study.

      The researchers also intend to conduct a larger study next year with diabetic participants. Additionally, they are working to ensure the accuracy of readings across different skin tones, which is a crucial step before the device can reach the mainstream market.

      Will there be a wearable version?

      Indeed, and sooner than expected. The team has already constructed a smaller prototype, approximately the size of a cellphone, and is currently testing it with healthy and prediabetic volunteers. The aim is to eventually reduce it to a size similar to a smartwatch.

      If these tests prove successful, accurate blood glucose monitoring could soon be available on smartwatches, representing a significant advancement for diabetic patients.

      Moreover, MIT is not the only player in this area. Companies like Huawei are also exploring diabetes risk detection for their smartwatches. We hope these innovations are made public soon, as they have the potential to enhance our lives.

      Though it's still early, the era of finger pricks may genuinely be coming to an end.